IDH1 and central nervous system cancer: A study by Unruh and colleagues demonstrated that the extent and targets of the DNA hypermethylation induced by mutant IDH are highly variable between various IDH mutant cancers (AML, cholangiocarcinomas, melanomas, gliomas), depending on the cellular contexts.